| Literature DB >> 33988163 |
Bruno Sposato1, Leonardo Croci2, Maurizio Di Tomassi3, Camilla Puttini4, Carmela Olivieri5, Mario Alessandri6, Maria Cristina Ronchi7, Elisa Donati8, Alessio Garcea9, Angelica Brazzi10, Maria Giovanna Migliorini11, Silvia Chigiotti12, Nikolaos Nikiforakis13, Tiziana Carli14, Elena Canneti15, Francesco Strambio16, Cristina Cellini17, Claudia Nardangeli18, Maria Pia Allegri19, Francesco Bianchi18, Claudio Bettini20, Marco Perruzza18, Nicola Lanzarone18, Lucia Valentini18, Paolo Orselli18, Marco Solari21, Salvatore Cardaci22, Marco Nofri22, Giorgia Angeli22, Francesca Mangani22, Elio Aloia22, Alessandro Lanari22, Marta Corridi23, Genni Spargi24, Antonio Perrella25, Cesira Nencioni26.
Abstract
Authors present 6 cases of abdominal bleeding associated with COVID-19, representing 1.35% of all hospitalized COVID-19 patients and hypothesize that there could be, although not very frequently, a relationship between SARS-CoV2 and bleeding. They excluded a side effect of the low molecular weight heparin therapy that all patients underwent during the course of the disease or other possible causes. Alterations of the coagulation state or a weakness of the vascular wall due toa presumed endotheliitis SARS-CoV-2 infection induced, are hypothesized by the authors. Investigation and follow-up for possible hemorrhagic problems in patients with COVID-19 is recommended. In particular, clinicians should be vigilant about retroperitoneal hemorrhage in COVID-19 patients. In addition to the fact that these patients are being treated with anticoagulants, anemia and abdominal pain are the signs that should lead us to suspect this type of haemorrhage. More studies are needed to understand if COVID-19 can be directly associated with bleeding. (www.actabiomedica.it)Entities:
Year: 2021 PMID: 33988163 DOI: 10.23750/abm.v92i2.10142
Source DB: PubMed Journal: Acta Biomed ISSN: 0392-4203